Search Results

You searched for : Octapharma

	Positive Results From ProDERM Study of octagamÂ® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020 Octapharma announces that the final results from the phase III ProDERM study will be presented at the American College of Rheumatology (ACR) Convergence 2020 virtual ... Nov 07
	Octapharma announces FDA approval of updated NUWIQÂ® Prescribing Information to include immunogenicity data in previously untreated patients The development of inhibitors against exogenous FVIII can reduce the effectiveness of treatment and negatively impact a patient's long-term joint health and quality ... Oct 20
	Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019 Octapharma has seven R&D sites and six state-of-the-art manufacturing facilities in Austria, France, Germany, Mexico and Sweden, in addition to more ... Feb 17
	Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders Octapharma demonstrates commitment to improving haemophilia, a treatment at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)... Feb 08
	Update of Summary of Product Characteristics for NuwiqÂ® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis Octapharma announced today that the European Medicines Agency has authorised an updated Summary of Product Characteristics (SmPC) for NuwiqÂ® that includes information on personalised prophylaxis ... Oct 01
5 Matching result(s) found!

-Advertisements-

Trending Now
	Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
	Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
	Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024
	Challenges of Child Growth at High Altitudes: New Study Reveals ImpactApril 26, 2024
	Staying Cool in India's Scorching Heat: Heatwave Safety TipsApril 26, 2024
	The Dark Side of Neotame (Artificial Sweetener): New Research Raises Concerns about Gut HealthApril 26, 2024
	Sightsavers India Fellowship Program Invites Applications for Promising OphthalmologistsApril 25, 2024
	Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
	The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
	Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
	The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
	FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
	Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
	Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
	10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
	Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
	Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
	The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
	Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
	After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024

Search Results

Positive Results From ProDERM Study of octagamÂ® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020

Octapharma announces FDA approval of updated NUWIQÂ® Prescribing Information to include immunogenicity data in previously untreated patients

Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019

Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders

Update of Summary of Product Characteristics for NuwiqÂ® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis

Trending Now